Pearce N - Search Results

1

Confounding by severity does not explain the association between fenoterol and asthma death.

Beasley R, Burgess C, Pearce N, Woodman K, Crane J. Beasley R, et al. Among authors: pearce n. Clin Exp Allergy. 1994 Jul;24(7):660-8. doi: 10.1111/j.1365-2222.1994.tb00970.x. Clin Exp Allergy. 1994. PMID: 7953948

2

Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics.

Bremner P, Burgess C, Beasley R, Woodman K, Marshall S, Crane J, Pearce N. Bremner P, et al. Among authors: pearce n. Respir Med. 1992 Sep;86(5):419-23. doi: 10.1016/s0954-6111(06)80009-0. Respir Med. 1992. PMID: 1462021 Clinical Trial.

3

Cardiovascular effects of fenoterol under conditions of hypoxaemia.

Bremner P, Burgess CD, Crane J, McHaffie D, Galletly D, Pearce N, Woodman K, Beasley R. Bremner P, et al. Among authors: pearce n. Thorax. 1992 Oct;47(10):814-7. doi: 10.1136/thx.47.10.814. Thorax. 1992. PMID: 1481183 Free PMC article.

4

Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma.

Crane J, Pearce N, Burgess C, Woodman K, Robson B, Beasley R. Crane J, et al. Among authors: pearce n. Int J Epidemiol. 1992 Aug;21(4):737-44. doi: 10.1093/ije/21.4.737. Int J Epidemiol. 1992. PMID: 1521979

5

Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study.

Woodman K, Pearce N, Beasley R, Burgess C, Crane J. Woodman K, et al. Among authors: pearce n. Clin Pharmacol Ther. 1992 May;51(5):566-71. doi: 10.1038/clpt.1992.64. Clin Pharmacol Ther. 1992. PMID: 1587070

6

Comparison of a video questionnaire with the IUATLD written questionnaire for measuring asthma prevalence.

Shaw RA, Crane J, Pearce N, Burgess CD, Bremner P, Woodman K, Beasley R. Shaw RA, et al. Among authors: pearce n. Clin Exp Allergy. 1992 May;22(5):561-8. doi: 10.1111/j.1365-2222.1992.tb00166.x. Clin Exp Allergy. 1992. PMID: 1628254

7

Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma.

Burgess CD, Windom HH, Pearce N, Marshall S, Beasley R, Siebers RW, Crane J. Burgess CD, et al. Among authors: pearce n. Am Rev Respir Dis. 1991 Feb;143(2):444-6. doi: 10.1164/ajrccm/143.2.444. Am Rev Respir Dis. 1991. PMID: 1671326 Clinical Trial.

8

Beta agonists and asthma mortality: déjà vu.

Pearce N, Crane J, Burgess C, Jackson R, Beasley R. Pearce N, et al. Clin Exp Allergy. 1991 Jul;21(4):401-10. doi: 10.1111/j.1365-2222.1991.tb01679.x. Clin Exp Allergy. 1991. PMID: 1680532 Review. No abstract available.

9

Asthma mortality and inhaled beta agonist therapy.

Beasley R, Pearce N, Crane J, Windom H, Burgess C. Beasley R, et al. Among authors: pearce n. Aust N Z J Med. 1991 Oct;21(5):753-63. doi: 10.1111/j.1445-5994.1991.tb01385.x. Aust N Z J Med. 1991. PMID: 1684702 Review. No abstract available.

10

The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma.

Windom HH, Burgess CD, Siebers RW, Purdie G, Pearce N, Crane J, Beasley R. Windom HH, et al. Among authors: pearce n. Clin Pharmacol Ther. 1990 Sep;48(3):296-301. doi: 10.1038/clpt.1990.152. Clin Pharmacol Ther. 1990. PMID: 1976051 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

988 results

Search Page